Validated Instrument Automation
Caprini score and Padua prediction score inputs are extracted from structured chart data, computing results automatically rather than depending on manual form completion.
Custom Software
AI VTE Prediction Software Development
AI VTE prediction software automates venous thromboembolism risk assessment using validated instruments such as Caprini and Padua, pulling data from the chart rather than requiring manual entry, and routes results into prophylaxis workflow. It functions as decision support only: the prescriber decides all prophylaxis, and no anticoagulation is ordered automatically.
VTE prophylaxis is a solved clinical problem with an unsolved workflow problem: the scoring instruments are validated and the guidelines are clear, yet assessment is frequently skipped or completed from memory. Taction Software builds AI VTE prediction tooling that automates the assessment step so the clinical decision is made with complete information.
Tell Us Your Requirements
Our experts are ready to understand your business goals.
Trusted Partners
Trusted by Industry Leaders Worldwide
Recognition
Awards & Recognitions
What Is AI VTE Prediction Software
AI VTE prediction software refers to automation and machine learning applied to venous thromboembolism risk assessment: extracting scoring inputs from the chart, computing validated instrument scores, flagging assessment gaps, and routing results into prophylaxis ordering workflow. Unlike many prediction categories, the underlying instruments here are already validated, so the primary contribution is eliminating manual data gathering and missed assessments rather than inventing new risk models. Every prophylaxis decision stays with the prescriber. This work sits inside our broader healthcare AI practice.
Bleeding Risk Assessment
Bleeding risk is assessed alongside thrombotic risk, since prophylaxis decisions require both, and presenting one without the other distorts the clinical picture.
Assessment Gap Detection
Gap detection flags admissions lacking documented VTE assessment, addressing the compliance failure mode that quality programs most frequently encounter.
Prophylaxis Workflow Routing
Results route into ordering workflow, complementing computerized order entry where prophylaxis orders are placed by the prescriber.
Contraindication Surfacing
Documented contraindications including active bleeding, thrombocytopenia, and planned procedures are surfaced so the prescriber weighs them explicitly.
Decision Support Boundaries
Every output carries clinical decision support framing. The software does not order anticoagulation, determine dosing, or override prescriber judgment in any configuration.
Core AI VTE Prediction Services
Our AI VTE prediction services cover data extraction, instrument automation, workflow integration, quality reporting, and monitoring. This category is unusual in that success is mostly an integration and workflow achievement rather than a modeling one, since the instruments are already validated. That means the value depends almost entirely on whether extraction is accurate and whether the assessment appears at the right moment in admission workflow. Engagements typically open with a review of chart data availability and current assessment compliance. Deliverables are structured so clinical, pharmacy, and quality stakeholders can review independently.
01
Chart Data Extraction
We build extraction for instrument inputs from structured fields and, where necessary, clinical text, with data provenance recorded for every value contributing to a score.
02
Instrument Implementation
We implement validated instruments faithfully to published specification, with version control so score changes over time remain attributable and auditable.
03
EHR Workflow Integration
Assessment must appear during admission workflow. Our EHR and EMR integration practice covers admission workflow placement and write-back.
04
Prophylaxis Order Support
Order support presents guideline-consistent options for prescriber selection, with mechanical prophylaxis and pharmacologic options both surfaced rather than defaulting to one.
05
Medication Interaction Context
Prophylaxis interacts with existing medications, connecting with AI medication reconciliation for medication context at the point of decision.
06
Quality Measure Reporting
Structured capture supports PSI-12 and related quality reporting, drawing on our MIPS and MACRA reporting automation work for submission preparation.
Benefits of AI VTE Prediction Software
The benefits of AI VTE prediction concentrate in assessment completeness, documentation quality, and reduced clinician data gathering. Manual VTE assessment requires pulling age, BMI, history, procedure details, and mobility status from several places, and under admission pressure it is often skipped or completed approximately. Automating extraction addresses that directly. We publish no figures on VTE rates, prophylaxis compliance, or quality scores, because those depend entirely on your baseline and patient population. What we deliver is instrumentation so your program measures its own performance.
Higher Assessment Completeness
Automated extraction and gap flagging address missed assessments, which is the dominant failure mode in VTE prophylaxis programs rather than incorrect scoring.
Reduced Data Gathering
Pulling inputs from the chart removes the manual collection burden, so clinicians spend attention on the prophylaxis decision rather than assembling the score.
Balanced Risk Presentation
Presenting thrombotic and bleeding risk together supports better decisions than instruments viewed in isolation, which is how they are frequently used.
Cleaner Quality Documentation
Structured assessment records support quality measure reporting without retrospective chart abstraction, which currently consumes substantial quality staff time.
Consistent Guideline Application
Automated assessment applies the same criteria at every admission, reducing variation driven by admission volume and time of day rather than clinical difference.
Auditable Score Provenance
Recording which data produced each score creates an audit trail, so a disputed assessment can be reconstructed rather than defended from memory.
Our AI VTE Prediction Process
We deliver AI VTE prediction projects in gated phases so clinical stakeholders approve direction before engineering cost accumulates. Discovery establishes intended use, data availability for instrument inputs, and current assessment compliance. Because the instruments are validated, the critical validation work here is extraction accuracy rather than model discrimination: a faithfully implemented Caprini score computed from wrong inputs is worse than no automation, so we verify extraction against manual review before anything reaches clinical use.
Discovery and Compliance Baseline
Discovery defines intended use, measures current assessment completeness, and identifies which instrument inputs are reliably available in structured form.
Extraction Development and Verification
We build extraction and verify accuracy against manual chart review, since automation computing correct math from incorrect inputs is actively harmful.
Instrument Validation
We confirm instrument fidelity against published specifications with test cases, so scores match what a correctly completed manual assessment would produce.
Workflow Placement Design
We design placement inside admission workflow, because an assessment appearing after orders are written provides documentation without influencing care.
Silent Mode Verification
The system runs in silent deployment, comparing automated scores against clinician assessments so agreement is quantified before clinical display.
Rollout and Ongoing Support
Rollout expands by unit with compliance dashboards, quality committee review, and continuing support as guidelines and instruments are updated.
Technology and Compliance
VTE prediction software handles PHI and produces output feeding directly into medication ordering, which places it closer to prescribing workflow than most prediction tools. Taction holds ISO 27001 certification and follows HIPAA-aligned engineering practice. Where assessment output is intended to guide prophylaxis decisions, SaMD classification may apply. The specific technical concern here is extraction fidelity: because clinicians will reasonably trust an automated score, incorrect extraction is more dangerous than no automation, and validation must be proportionate to that trust.
HIPAA-Aligned Engineering
Builds apply encryption in transit and at rest, role-based access, and complete audit logging. Our HIPAA compliance software development practice defines these controls.
SaMD and FDA Considerations
Assessment output guiding prophylaxis may trigger SaMD classification. Our FDA SaMD compliance services cover design history, validation, and change control.
Extraction Accuracy Validation
Extraction validation against manual review is mandatory, because automation that computes correct scores from wrong inputs creates false confidence at scale.
Instrument Version Control
Instrument versioning is tracked, so scores remain attributable to the specification version in force when they were produced and remain auditable later.
Guideline Update Management
Published guidance changes. We treat guideline updates as maintained deliverables with clinical review rather than silent configuration changes.
Deployment Security
Deployments run on-premise, in your cloud tenancy, or hybrid, with network segmentation, signed container images, and documented penetration testing before release.
Why Choose Taction Software
Taction Software was founded in 2013 and has spent over 12 years building healthcare software, delivering more than 200 healthcare projects from four US offices in Chicago, Cheyenne, Austin, and Sacramento, with ISO 27001 certification. Our relevant strength here is treating extraction accuracy as the actual engineering problem. Many vendors emphasize the model; in VTE the instruments already work, and the difference between a useful tool and a dangerous one is whether the inputs are right. Our leadership brings more than 20 years of personal experience in the field.
01
Extraction Accuracy Focus
We validate data extraction against manual review rather than assuming structured fields are complete, which is where automated scoring most often goes wrong.
02
Established Healthcare Focus
Founded in 2013, we have concentrated on healthcare rather than treating it as one vertical among several, producing depth in clinical workflow and ordering systems.
03
EHR and Clinical Systems Depth
Our Voyant Health EHR and EMR work means EHR integration and admission workflow placement are handled by engineers with clinical systems experience.
04
Regulated Product Experience
We delivered the FDA-registered applications Revive Ease and PainKare, so design controls and validation documentation are established practice.
05
Decision Support Engineering
We build clinical decision support with prescriber authority preserved, detailed in our clinical decision support software development practice.
06
Certified Security Posture
ISO 27001 certification and HIPAA-aligned engineering mean security controls are documented and auditable, supporting your vendor risk assessment efficiently.
Pricing
AI VTE prediction pricing depends on scope, data availability, service line count, and integration depth. Automating one instrument for medical admissions costs considerably less than a system covering surgical, orthopedic, and obstetric populations with distinct instruments and order integration. We price after discovery, because extraction feasibility depends heavily on how much required data sits in structured fields versus narrative text. Discovery produces an itemized, fixed-scope estimate with phase-level breakdown. Cloud infrastructure and third-party licensing are separate from engineering and itemized clearly.
MVP or Single Module
An MVP automating one instrument for one population typically runs $40,000 to $80,000, including extraction validation against manual review.
Full Platform Build
A full platform covering multiple populations, order integration, gap detection, and quality reporting typically falls between $80,000 and $200,000.
Enterprise Deployment
Enterprise engagements covering multi-facility rollout, service-specific instruments, and regulatory documentation start at $200,000 and scale with facility count.
Discovery Phase Scoping
Discovery is a paid, time-boxed phase producing an itemized estimate, architecture plan, and extraction feasibility assessment. It is separable so you can evaluate our work first.
Cost Drivers to Expect
Structured data availability, service line count, order integration depth, and text extraction requirements are the largest variables, identified during discovery for budget planning.
Ongoing Support Costs
Post-launch guideline updates, extraction monitoring, instrument revisions, and support are quoted separately as a retainer sized to your facility count.
Get Started
If you are evaluating AI VTE prediction for assessment automation, prophylaxis workflow, or PSI-12 quality performance, the fastest next step is a discovery call with our clinical engineering team. We will assess extraction feasibility against your chart data, review current assessment compliance, and return an itemized, fixed-scope estimate. Contact us to schedule that conversation.
FAQs
Frequently Asked Questions
Hospitals evaluating AI VTE prediction usually ask why automation is needed given that the instruments already exist, how extraction accuracy is verified, and whether the system orders prophylaxis. The answers below reflect how we scope these projects. If your scope includes obstetric or pediatric populations, note that instrument selection differs materially and should be discussed explicitly.
Because the failure is workflow, not scoring. Assessment requires assembling age, BMI, history, procedure, and mobility data from several places, and under admission pressure it is skipped or approximated. Automating extraction addresses the actual gap, which is missed and incomplete assessment rather than incorrect arithmetic.
No. It computes risk, surfaces bleeding risk and contraindications, and presents guideline-consistent options, but the prescriber selects and orders all prophylaxis. The software does not order medication, determine dosing, or default to a pharmacologic option in any configuration we build.
Against manual chart review on a validation sample before clinical use, and with ongoing monitoring afterward. This is the critical validation step, because clinicians will reasonably trust an automated score, and correct math on wrong inputs creates confident errors at scale rather than obvious ones.
An MVP for one instrument and population runs $40,000 to $80,000. A full platform typically falls between $80,000 and $200,000. Enterprise multi-facility deployments start at $200,000. Discovery produces an itemized, fixed-scope estimate, with infrastructure quoted separately from engineering.
Only with pregnancy-specific instruments, since Caprini and Padua are not validated for pregnancy and postpartum populations. Applying general adult scoring to obstetric patients would be clinically inappropriate, so obstetric scope requires separate instrument selection with your maternal health clinicians.
Guideline and instrument updates are handled as maintained deliverables with clinical review before deployment, not silent configuration edits. Prior scores remain attributable to the specification version in force when produced, so historical assessments stay auditable after an update.